Questioning the Effectiveness of Addiction Treatments

What is the Evidence?
  • A. Thomas McLellan

Abstract

Some of the most significant economic and social problems facing society are associated with alcohol and drug dependence (National Institute on Drug Abuse, 1991; Merril, 1993). In the United States alone, it has been estimated that alcohol abuse costs approximately $90 billion and that abuse of other drugs costs approximately $67 billion each year (Rice, Kellman, and Miller, 1991). In terms of public health and safety, many studies have shown that one fifth to one fourth of all deaths annually are associated in some way with alcohol, drug or tobacco use (Horgan, 1994). Finally, the social deterioration associated with substance abuse is illustrated by the fact that more than three-fourths of all foster children in the U.S. are the offspring of alcohol and/or drug dependent parents (Childrens Defense Fund Report, 1994).

Keywords

Placebo Obesity Nicotine Cocaine Assure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allison M. and Hubbard R.L. Drug abuse treatment process: A review of the literature. TOPS Research Monograph. Raleigh, N.C.: Research Triangle Press, 1982.Google Scholar
  2. Alterman A.I. and Cacciola J.S. The antisocial personality disorder diagnosis in substance abusers. Journal of Nervous and Mental Disorders, 179:401–409, 1991.CrossRefGoogle Scholar
  3. Anglin M.D. and Hser Y. Legal Coercion and Drug Abuse Treatment. In J. Inciardi Handbook on Drug Control in the United States. Westport Conn., Greenwood Press, 1990.Google Scholar
  4. Anglin M.D., Speckart G.R. and Booth, M.W. Consequences and Costs of Shutting off Methadone. Addictive Behaviors, 14(3):307–326, 1989.PubMedCrossRefGoogle Scholar
  5. Armor D.J., Polich J.M. and Stambul H.B. Alcoholism and Treatment. Santa Monica Ca., RAND Corp. Press, 1976.Google Scholar
  6. Azrin N.H., Sisson R.W., Meyers R., and Godley M. A social-systems approach to resocializing alcoholics in the community. Journal of Studies on Alcohol, 43:1115–1123, 1982.Google Scholar
  7. Azrin N.H. Improvements in the community reinforcement approach to alcoholism. Behavior Research and Therapy, 14:339-348, 1976.CrossRefGoogle Scholar
  8. Babor T., Dolinsky Z., Rounsaville B.J. and Jaffe J. Unitary versus multidimensional models of alcoholism treatment outcome: An empirical study. J. Stud. Alc., 49:167–177, 1988.Google Scholar
  9. Ball J.C. and Ross A. The Effectiveness of Methadone Maintenance Treatment. New York, Springer-Verlag, 1991.CrossRefGoogle Scholar
  10. Ball J.C., Meyers, C.P., and Friedman S.R. Reducing the Risk of AIDS Through Methadone Maintenance Treatment. J.Health and Social Behavior. 29(3):214–226, 1988.CrossRefGoogle Scholar
  11. Brown J.M. and Miller W.R. (1993) Impact of motivational interviewing on participation and outcome in residential alcoholism treatment. Psychology of Addictive Behaviors, 7:211–218.CrossRefGoogle Scholar
  12. Childrens Defense Fund Report, Washington D.C., 1994.Google Scholar
  13. Clark L.T Improving compliance and incrasing control of hypertension: Needs of special hypertensive populations. American Heart Journal, 121 (2 pt 2):664–669, 1991PubMedCrossRefGoogle Scholar
  14. Cornish J., Metzger D., Woody G., Wilson D., McLellan A.T., Vandergrift B. and O’Brien C.P. Naltrexone pharmacotherapy for opioid dependent federal probationers. J . Substance Abuse Treatment, 13:477–489, 1998.Google Scholar
  15. Dekker F.W., Dieleman F.E. and Kaptein A.A. Compliance with pulmonary medication in general practice. European Respiratory Journal, 6(6):886–890, 1993.PubMedGoogle Scholar
  16. DeLeon, G. The Therapeutic Community: Study of Effectiveness. Treatment Research Monograph #84-1286, NIDA, Rockville, Md., 1984.Google Scholar
  17. Duffy DL, Martin NG, Battistutta D, Hopper JL, Mathews JD. Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis. 1990;142:1351–1358.PubMedGoogle Scholar
  18. Edwards G., Orford J., Egert S., Guthrie A., Hawker C, Hensman M., Mitcheson M., Oppenheimer E. and Taylor C. Alcoholism: A controlled trial of treatment and advice, J. Stud. Alc, 38:1004–1031, 1977.Google Scholar
  19. Emrick CD. A review of psychologically oriented treatments for alcoholism II. The relative effectiveness of different treatment approaches and the effectiveness of treatment versus no treatment. J. Stud. Alc. 36:88–108, 1975.Google Scholar
  20. Fagard R, Brguljan J, Staessen J et al. Heritability of conventional and ambulatory blood pressures: a study in twins. Hypertension, 26:919–924, 1995.PubMedCrossRefGoogle Scholar
  21. Finney J.W., Moos R.H. and Chan D.A. Length of Stay and Program Component Effects in the Treatment of Alcoholism: A Comparison of Two Techniques for Process Analyses. Journal of Consulting and Clinical Psychology, 49:120–131, 1981.PubMedCrossRefGoogle Scholar
  22. Food and Drug Administration, Compliance Policy Guidelines, Associate Comm. for Regulatory Affairs, 21 CFR 310, October, 1980.Google Scholar
  23. Gerstein D. and Harwood H. (Editors) Treating Drug Problems (Volume One). Washington D.C, National Academy Press, 1990.Google Scholar
  24. Gerstein D., Judd L.L. and Rovner S.A. Career dynamics of female heroin addicts. Am. J. Drug and Alc. Abuse, 6(l):l–23, 1979.Google Scholar
  25. Graber A.L., Davidson P., Brown A., McRae J. and Woolridge K. Dropout and relapse during diabetes care. Diabetic Care, 15(11):1477–1483, 1992.CrossRefGoogle Scholar
  26. Havassy B.E., Wasserman D. and Hall S.M. Social relationships and cocaine use in an American treatment sample. Addiction, 58:456–460, 1995.Google Scholar
  27. Hesselbrock V., Meyer R and Keener J. Psychopathology in hospitalized alcoholics. Archives of General Psychiatry, 42:1050–1055, 1985.PubMedCrossRefGoogle Scholar
  28. Higgins S.T., Budney A.J., Bickel W.K., et al. Incentives improve treatment retention, cocaine abstinence and psychiatric symptomatology in ambulatory cocaine dependent patients. Am. J. Psychiatry, 151:223–225, 1994.Google Scholar
  29. Higgins S.T., Budney A.J., Bickel W.K. and Badger G.J. Participation of significant others in outpatient behavioral treatment predicts greater cocaine abstinence. Am. J. Drug and Alcohol Abuse, 45:322–327, 1993.Google Scholar
  30. Higgins S.T., Delaney D.D., Budney A.J., et al. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiat., 148:1218–1224, 1991.PubMedGoogle Scholar
  31. Horgan C. Chartbook of Social Indicators for Substance Abuse. Princeton, N.J., Robert Wood Johnson Foundation Report., 1994.Google Scholar
  32. Horowitz R.I. Treatment adherence and risk of death after a myocardial heart infarction. Lancet, 336(8714):542–545, 1993CrossRefGoogle Scholar
  33. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R. and Ginzburg H.M. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill: Univ. of North Carolina Press. 1989.Google Scholar
  34. Hunt G.M. and Azrin N.H. A community reinforcement approach to alcoholism. Behavior Research and Therapy, 11:91–104, 1973.CrossRefGoogle Scholar
  35. Inciardi J.A. Some considerations on the clinical efficacy of compulsory treatment: the New York experience. In C. G. Leukefeld and F. M. Tims (Eds.) Compulsory Treatment of Drug Abuse: Research and Clinical Practice. NIDA Research Monograph 86: 1988.Google Scholar
  36. Joe G.W., Simpson D.D. and Sells S.B. Treatment process and relapse to opioid use during methadone maintenance. Am. J. Drug and Alcohol Abuse, 19:124–130, 1992.Google Scholar
  37. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 and type 2 diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia, 1992;35:1060–1067.PubMedCrossRefGoogle Scholar
  38. Kendler KS, Prescott C. Cannabis use, abuse and dependence in a population-based sample of female twins Am J Psychiatry. 1998;155:1016–1022.PubMedGoogle Scholar
  39. Kurtz S. M. Adherence to diabetic regimes: Empirical status and clinical applications. Diabetes Education, 16(l):50–59, 1990.CrossRefGoogle Scholar
  40. Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ, 311:913–917, 1995.PubMedCrossRefGoogle Scholar
  41. LaPorte, D., McLellan, A.T., Erdlen, F. Alcohol and drug abuse treatment outcome as a function of follow-up difficulty. J. Clin and Consult. Psychology, 49(1):112–119, 1981.CrossRefGoogle Scholar
  42. Longabaugh R., Beattie M., Noel N., Stout R. and Malloy P. The effect of social investment on treatment outcome. Journal of Studies on Alcohol, 56:16–21, 1994.Google Scholar
  43. Maddux J.F. and Desmond D.P. Relapse and recovery in substance abuse careers. In F. M. Tims and C. G. Leukefeld (Eds.) Relapse and Recovery in Drug Abuse, NIDA Research Monograph Series 72, DHHS Pub. No. (ADM) 86–1473, Rockville Md., 1986.Google Scholar
  44. McLellan A.T., O’Brien C.P. and Kleber H.D. Drug addiction as a chronic medical illness: Implications for treatment, insurance and evaluation. JAMA, 284:1689–1695, 2000.PubMedCrossRefGoogle Scholar
  45. McLellan A.T. and McKay J. The treatment of addiction: What can research offer practice? In Lamb S. and McCarty D. (Eds.) Bridging the Gap: Forging new partnerships in community-based drug abuse treatment. 1998. Washington, DC: National Academy Press.Google Scholar
  46. McLellan A.T., Arndt I.O., Woody G.E. and Metzger D. Psychosocial Services in Substance Abuse Treatment?: A dose-ranging study of psychosocial services. J. Am. Med. Assn., 269(15):1953–1959, 1993.CrossRefGoogle Scholar
  47. McLellan A.T., Grissom G., Alterman A.I., Brill, P. and O’Brien C.P. Substance Abuse Treatment in the Private Setting: Are some programs more effective than others? J. Substance Abuse Treatment, 10:243–254, 1993.CrossRefGoogle Scholar
  48. McLellan A.T., Metzger D., Alterman A.I. et al. How effective is substance abuse treatment- Compared to what? In C.P. O’Brien and J. Jaffe (Editors) Advances in Understanding the Addictive States. N.Y., Raven Press, 1992.Google Scholar
  49. McLellan A.T., Alterman A.I., Woody G.E. A quantitative measure of substance abuse treatments: The Treatment Services Review. J. Nerv. Ment. Dis., 180:101–110, 1992.PubMedCrossRefGoogle Scholar
  50. McLellan, A.T., Luborsky, L., Woody, G.E., O’Brien, C.P., Druley, K.A. Increased effectiveness of substance abuse treatment: A prospective study of patient-treatment “matching”, J. Nerv. Ment. Dis., 171(10):597–605, 1983.PubMedCrossRefGoogle Scholar
  51. McLellan, A.T., Druley, K.A., O’Brien, C.P., Kron, R. Matching substance abuse patients to appropriate treatments. A conceptual and methodological approach, Drug and Alcohol Dependence, 5(3):189–193, 1980.Google Scholar
  52. Merrill, J. The Cost of Substance Abuse to America’s Health Care System. Center on Addiction and Substance Abuse, Columbia University, NY, NY 1993.Google Scholar
  53. Metzger D., Woody G.E., DePhillipis D., et al. Risk factors for needle sharing among methadone patients. Am. J. Psychiatry, 121:1113–1116, 1992.Google Scholar
  54. Miller W.R. and Hester, R.K. The Effectiveness of Alcoholism Treatment Methods. In Miller, W.R. and Heather, N. (Eds.) Treating Addictive Behaviors: Process of Change, New York: Plenum Press, 1986.CrossRefGoogle Scholar
  55. Miller W. R., Walters S. T., and Bennett M. E. How effective is alcoholism treatment? Journal of Studies on Alcohol, 62:211–220, 2001.PubMedGoogle Scholar
  56. Mitchell BD, Kammerer CM, Blangero J, et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. Circulation, 94:2159–2170, 1996.PubMedCrossRefGoogle Scholar
  57. Moos R.H., Finney J.W. and Cronkite R.C. Alcoholism Treatment: Context, Process and Outcome. New York, Oxford Univ. Press., 1990.Google Scholar
  58. Moos, R.H. Evaluating Treatment Environments. New York: Wiley, 1974.Google Scholar
  59. National Institute on Drug Abuse, See How Drug Abuse Takes the Profit Out of Business, Dept. of Health and Human Services USGPO, 1991.Google Scholar
  60. Nieminen MM, Kaprio J, and Koskenvuo M. A population-based study of bronchial asthma in adult twin pairs. Chest, 100:70–75, 1991.PubMedCrossRefGoogle Scholar
  61. O’Brien C.P. and McLellan A.T. Myths about the treatment of addiction. Lancet 347:237–240,1996.CrossRefGoogle Scholar
  62. Pattison E.M. Evaluation of alcoholism treatment: A comparison of three facilities. Arch Gen Psychiat. 20:478–483, 1969.PubMedCrossRefGoogle Scholar
  63. Rice D.P., Kelman S., and Miller L.S. Estimates of the economic costs of alcohol, drug abuse and mental illness, 1985 and 1988. Public Health Reports, 106(3):281–292, 1991.Google Scholar
  64. Rounsaville B.J., Dolinsky Z.S., Babor T.F. and Meyer R.E. (1987) Psychopathology as a predictor of treatment outcome in alcoholics. Arch. Gen Psychiat., 44:505–513, 1987.PubMedCrossRefGoogle Scholar
  65. Rounsaville B.J., Wilber C.H. and Kleber H. Short-term interpersonal psychotherapy in methadone maintained opiate addicts. Arch. Gen. Psychiat., 40:619–626, 1983.CrossRefGoogle Scholar
  66. Rua J. Treatment Works: The Tragic Cost of Undervaluing Treatment in the Drug War. Paper presented at the “What Works: An International Perspective on Drug Abuse Treatment” conference. New York. New York State Division of Substance Abuse Services, 1989.Google Scholar
  67. Saxe L., Dougherty D. and Fine M. The Effectiveness and Costs of Alcoholism Treatment. Case Study 22. Office of Technology Assessment. Washington D.C., 1983Google Scholar
  68. Schuckit M.A. The clinical implications of primary diagnostic groups among alcoholics. Arch. Gen. Psychiat, 42:1043–1049, 1985.PubMedCrossRefGoogle Scholar
  69. Simpson D. and Savage L. Drug abuse treatment readmissions and outcomes, Arch. Gen. Psychiat. 37:896–901, 1980.PubMedCrossRefGoogle Scholar
  70. Sisk J.E., Hatziandreu, E.J. and Hughes R. The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection, Office of Technology Assessment, Background Paper No. 6, USGPO No. 052-003-01210-3, Washington D.C., 1990.Google Scholar
  71. Svetkey L.P., McKeown S.P., and Wilson A.F. Heritability of salt sensitivity in black Americans. Hypertension, 28:854–858, 1996.PubMedCrossRefGoogle Scholar
  72. True WR and Xian H. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch. Gen. Psychiatry. 1999;56:655–661.PubMedCrossRefGoogle Scholar
  73. Tsuang MT, Lyons MJ, Eisen S, et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am. J. Med. Genet., 1996;67:473–477.PubMedCrossRefGoogle Scholar
  74. VandenBree M., Johnson E., Neale M., Pickens R. Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Dependence, 1998;52:231–241.CrossRefGoogle Scholar
  75. Wall Street Journal, Editorial Commentary, July 18, 1994, p. A12.Google Scholar
  76. Wexler M.K., Falkin G.P. and Lipton D.S. A Model Prison Rehabilitation Program. An Evaluation of the Stay’n Out Therapeutic Community. New York, NDRI Press., 1988.Google Scholar
  77. Williams RR, Hunt SC, Hasstedt SJ, et al. Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension, 1991;18(suppl): 129-137.CrossRefGoogle Scholar
  78. Woody G.E., McLellan A.T. and Luborsky L. Psychiatric severity as a predictor of benefits from psychotherapy. Am. J. Psychiat., 141(10):1171–1177, 1984.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • A. Thomas McLellan
    • 1
  1. 1.Department of PsychiatryUniversity of Pennsylvania, School of MedicinePhiladelphiaUSA

Personalised recommendations